AARS1涉及恶性和免疫透在头部和部状细胞癌,作为预后预测器
Shengkai Chen1,2,3, Yuanhe You1,2,3, Fangxing Zhu1,2,3
1Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
概括
头支状细胞癌 (HNSCC) 中AARS1的高表达与预后不佳和免疫逃避有关. 针对AARS1可能为HNSCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- AARS1的异常表达与各种癌症的瘤进展有关.
- 目前尚不清楚AARS1在头角状细胞癌 (HNSCC) 中的具体作用和机制.
研究的目的:
- 研究AARS1在HNSCC中的表达,预后意义和功能作用.
- 探索AARS1与HNSCC微环境中的免疫透之间的关联.
主要方法:
- 在HNSCC组织和细胞系中验证了AARS1表达.
- 使用生存分析 (Kaplan-Meier,Cox) 评估预后值.
- 通过扩散,迁移和亡分析评估了AARS1对HNSCC恶性瘤的影响.
- 使用生物信息学工具 (TIMER,CIBERSORT等) 分析免疫细胞透和免疫检查点. ) 的情况.
主要成果:
- 在HNSCC中,AARS1显著上调,与较差的生存结果相关 (OS,DSS,PFI).
- 通过AARS1的淘汰,抑制了HNSCC细胞的增殖,迁移和亡抵抗力.
- 高AARS1表达与减少CD8+T细胞透和增加Siglec-15和ITPRIPL1水平有关,这表明免疫逃避.
结论:
- 高AARS1表达是HNSCC中预后不佳和恶性行为的标志物.
- AARS1影响免疫透,可能促进HNSCC的免疫逃避.
- 在HNSCC治疗中,AARS1是一个潜在的治疗点.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Cancers Originate from Somatic Mutations in a Single Cell
14.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K


